RecruitingNot applicableNCT07168629

A Community Health Worker Intervention to Improve Lung Cancer Screening Uptake in Community Health Centers

Lung cancer screening (LCS) can reduce lung cancer-related mortality by 20%, but only 5-10% of eligible individuals have received an initial LCS. The goal of this study is to partner with community stakeholders to jointly develop and pilot test a multi-component community health worker-delivered intervention targeting key barriers to improve LCS and tobacco treatment utilization. The proposed activities will lay the groundwork for a subsequent R01 grant, conducting a fully powered randomized clinical trial to establish CHWs as an evidence-based practice that will facilitate access to screening and tobacco treatment, to reduce lung cancer mortality.

Checked against the public recordLast updated Aug 21, 2026 · Source: ClinicalTrials.gov

StatusRecruiting
PhaseNot applicable
U.S. locations1
SponsorBaystate Medical Center
01
Study overview

What this study is about

Purpose
Health Services Research
Study type
Interventional
Phase
Not applicable
Sponsor
Baystate Medical Center
Interventions being studied
Behavioral: Community health worker delivered outreach, shared decision-making, tobacco treatment, and navigation; Other: Enhanced Usual Care
02
Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

03
Public criteria

Who may be able to participate

Inclusion Criteria: * Adults between the age of 50 and 80. * Potentially eligible for LCS according to the Electronic Health Record smoking history. * Receive their primary care at Mason Square, High Street, or Brightwood community health centers. * English- or Spanish- speaking. Exclusion Criteria: * Not eligible for lung cancer screening based on age (age \< 50 or \> 80 years) or smoking history (has not smoked more than 20 pack-years of tobacco cigarettes or quit more than 15 years ago). * Have received a lung cancer screen in the past.

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

04
Study sites

U.S. locations

  • Baystate HealthSpringfield, Massachusetts

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Aug 21, 2026. Always confirm current availability with the study team.

View original record ↗